The landscape of dementia prognosis has advanced considerably with the advent of sophisticated biomarkers, which include amyloid PET scans, tau imaging, and blood-primarily based assessments that can detect Alzheimer's pathology several years prior to indicators arise. While these technological improvements characterize outstanding progress in comp